Gelatin-siloxane nanoparticles to deliver nitric oxide for vascular cell regulation: Synthesis, cytocompatibility, and cellular responses

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 3, 2015, Pages 929-938

  Zhang, Qin Yuan ^a   Wang, Zu Yong ^a   Wen, Feng ^b   Ren, Lei ^c   Li, Jun ^a   Teoh, Swee Hin ^d   Thian, Eng San ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c XIAMEN UNIVERSITY   (China)

^d Nanyang Technological University   (Singapore)

Author keywords

Controlled release; Nano particle; Nitric oxide; Vascular tissue engineering

Indexed keywords

CARDIOVASCULAR SYSTEM; CELLS; CYTOLOGY; DISEASES; ENDOTHELIAL CELLS; MUSCLE; NANOPARTICLES; NANOSYSTEMS; NITRIC OXIDE; SOL-GELS; TISSUE; TISSUE ENGINEERING; TISSUE HOMEOSTASIS;

CELLULAR RESPONSE; CONTROLLED RELEASE; CYTOCOMPATIBILITY; DOSE-DEPENDENT MANNER; HUMAN AORTIC SMOOTH MUSCLE CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL (HUVEC) CELLS; SOL-GEL CHEMISTRY; VASCULAR TISSUE ENGINEERING;

SYNTHESIS (CHEMICAL);

GELATIN; NANOPARTICLE; NITRIC OXIDE; SILOXANE;

ANIMAL CELL; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DISULFIDE BOND; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NITROSATION; NONHUMAN; SMOOTH MUSCLE FIBER; SURFACE CHARGE; SUSTAINED DRUG RELEASE; SYNTHESIS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD VESSEL; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MATERIALS TESTING; NANOTECHNOLOGY; PATHOLOGY; PROCEDURES; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; BLOOD VESSELS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; GELATIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATERIALS TESTING; MICE; MUSCLE, SMOOTH, VASCULAR; NANOPARTICLES; NANOTECHNOLOGY; NITRIC OXIDE; SILOXANES; SURFACE PROPERTIES; TISSUE ENGINEERING;

EID: 84923034178     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35239     Document Type: Article

References (52)

1. Janero DR, Ewing JF. Nitric oxide and postangioplasty restenosis: Pathological correlates and therapeutic potential. Free Radic Biol Med 2000; 29:1199-1221.
2. Weintraub WS. The pathophysiology and burden of restenosis. Am J Cardiol 2007; 100:3K-9K.
3. Scatena R, Bottoni P, Martorana G.E., Giardina B. Nitric oxide donor drugs: An update on pathophysiology and therapeutic potential. Expert Opin Investig Drugs 2005; 14:835-846.
4. Schwartz RS. Pathophysiology of restenosis: Interaction of thrombosis, hyperplasia, and/or remodeling. Am J Cardiol 1998; 81: 14E-17E.
5. Bredt D, Snyder S. Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 1994; 63:175-195.
6. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005; 111:2257-2273.
7. Miller MR, Megson IL. Recent developments in nitric oxide donor drugs. Br J Pharmacol 2007; 151:305-321.
8. Megson IL, Webb DJ. Nitric oxide donor drugs: Current status and future trends. Expert Opin Investig Drugs 2002; 11:587-601.
9. Polizzi MA, Stasko NA, Schoenfisch MH. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 2007; 23:4938-4943.
10. Shin JH, Metzger SK, Schoenfisch MH. Synthesis of nitric oxide-releasing silica nanoparticles. J Am Chem Soc 2007; 129:4612-4619.
11. Zhang XF, Mansouri S, Mbeh D.A., Yahia L., Sacher E, Veres T. Nitric oxide delivery by core/shell superparamagnetic nanopar-ticle vehicles with enhanced biocompatibility. Langmuir 2012; 28: 12879-12885.
12. Singh R, Lillard JW, Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009; 86:215-223.
13. Maragos CM, Morley D, Wink D.A., Dunams TM, Saavedra JE, Hoffman A, Bove A.A., Isaac L., Hrabie JA, Keefer LK. Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 1991; 34:3242-3247.
14. Jen MC, Serrano MC, van Lith R, Ameer GA. Polymer-based nitric oxide therapies: Recent insights for biomedical applications. Adv Funct Mater 2012; 22:239-260.
15. Wang Z, Zhao Y, Ren L., Jin L, Sun L, Yin P., Zhang Y, Zhang Q. Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy. Nanotechnology 2008; 19:445103.
16. Yin P, Wang J, Ren L., Wang ZY, Wang TX, Wang D, Tian M.M., Tian XH. Conjugation of membrane-destabilizing peptide onto gelatin-siloxane nanoparticles for efficient gene expression. Mater Sci Eng C-Mater Biol Appl 2010; 30:1260-1265.
17. Uchida E, Uyama Y, Ikada Y. Sorption of low-molecular-weight anions into thin polycation layers grafted onto a film. Langmuir 1993; 9:1121-1124.
18. Balthasar S, Michaelis K, Dinauer N., von Briesen H, Kreuter J, Langer K. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 2005:2723-2732.
19. Scott-Burden T, Schini VB, Elizondo E, Junquero D.C., Vanhoutte PM. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992; 71:1088-1100.
20. Seabra AB, de Oliveira MG. Poly(vinyl alcohol) and poly(vinyl pyr-rolidone) blended films for local nitric oxide release. Biomaterials 2004; 25:3773-3782.
21. Wen F, Magalhaes R, Gouk S.S., Bhakta G., Lee KH, Hutmacher DW, Kuleshova LL. Vitreous cryopreservation of nanofibrous tissue-engineered constructs generated using mesenchymal stro-mal cells. Tissue Eng Part C-Methods 2009; 15:105-114.
22. Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Methods 2008; 73:211-215.
23. Wang PG, Xian M, Tang X., Wu X, Wen Z, Cai T., Janczuk AJ. Nitric oxide donors: Chemical activities and biological applications. Chem Rev 2002; 102:1091-1134.
24. Zeta potential of colloids in water and waste water. ASTM Standard D 4187-82: American Society for Testing and Materials; 1985.
25. Williams DLH. The mechanism of nitric oxide formation from S-nitrosothiols (thionitrites). Chem Commun 1996:1085-1091.
26. De Palma R, Peeters S, Van Bael MJ, Van den Rul H, Bonroy K, Laureyn W, Mullens J, Borghs G, Maes G. Silane ligand exchange to make hydrophobic superparamagnetic nanoparticles water-dis-persible. Chem Mater 2007; 19:1821-1831.
27. Pavia DL, Lampman GM, Kriz GS. Introduction to Spectroscopy. Orlando: Harcourt College Publications; 2001.
28. Coates J. Interpretation of Infrared Spectra, A Practical Approach. Chichester: Wiley; 2000.
29. Li Y, Lee PI. Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. Mol Pharm 2010; 7:254-266.
30. Singh RJ, Hogg N, Joseph J., Kalyanaraman B. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem 1996; 271: 18596-18603.
31. International Organization for Standardization. Biological evaluation of medical devices. Part 5: Tests for in vitro cytotoxicity. Volume ISO 10993. Geneva; 2009.
32. Kue R, Sohrabi A, Nagle D., Frondoza C, Hungerford D. Enhanced proliferation and osteocalcin production by human osteoblast-like MG63 cells on silicon nitride ceramic discs. Biomaterials 1999; 20: 1195-1201.
33. des Rieux A, Fievez V, Garinot M., Schneider YJ, Preat V. Nano-particles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 2006; 116:1-27.
34. Yousefpour P, Atyabi F, Dinarvand R., Vasheghani-Farahani E. Preparation and comparison of chitosan nanoparticles with different degrees of glutathione thiolation. Daru 2011; 19:367-375.
35. Holmes AJ, Williams DLH. Reaction of ascorbic acid with S-nitro-sothiols: Clear evidence for two distinct reaction pathways. J Chem Soc Perkin Trans 2 2000:1639-1644.
36. Molina MM, Seabra AB, de Oliveira MG, Itri R, Haddad PS. Nitric oxide donor superparamagnetic iron oxide nanoparticles. Mater Sci Eng: C 2013; 33:746-751.
37. Duan XB, Lewis RS. Improved haemocompatibility of cysteine-modified polymers via endogenous nitric oxide. Biomaterials 2002; 23:1197-1203.
38. Frost MC, Meyerhoff ME. Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles. J Biomed Mater Res A 2005; 72:409-419.
39. Cui S, Reichner JS, Mateo R.B., Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res 1994; 54: 2462-2467.
40. Napoli C, Paolisso G, Casamassimi A., Al-Omran M, Barbieri M, Sommese L., Infante T, Ignarro LJ. Effects of nitric oxide on cell proliferation-Novel insights. J Am Coll Cardiol 2013; 62:89-95.
41. Napoli C, Paolisso G, Casamassimi A., Al-Omran M, Barbieri M, Sommese L., Infante T, Ignarro LJ. Effects of nitric oxide on cell proliferation novel insights. J Am Coll Cardiol 2013; 62:89-95.
42. Yu H, Payne TJ, Mohanty DK. Effects of slow, sustained, and rate-tunable nitric oxide donors on human aortic smooth muscle cells proliferation. Chem Biol Drug Des 2011; 78:527-534.
43. Su J, Groves JT. Mechanisms of peroxynitrite interactions with heme proteins. Inorg Chem 2010; 49:6317-6329.
44. Huang PL, Huang Z, Mashimo H., Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239-242.
45. Nishio E, Fukushima K, Shiozaki M., Watanabe Y. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun 1996; 221:163-168.
46. Fukuo K, Inoue T, Morimoto S., Nakahashi T, Yasuda O, Kitano S., Sasada R, Ogihara T. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest 1995; 95:669-676.
47. Ziche M, Parenti A, Ledda F., Dell'Era P, Granger HJ, Maggi CA, Presta M. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res 1997; 80:845-852.
48. Zheng J, Wen Y, Austin J.L., Chen DB. Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells. Biol Reprod 2006; 74:375-382.
49. Brookes PS, Salinas EP, Darley-Usmar K, Eiserich J.P., Freeman BA, Darley-Usmar VM, Anderson PG. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000; 275:20474-20479.
50. Nishikawa T, Iwakiri N, Kaneko Y., Taguchi A, Fukushima K, Mori H., Morone N, Kadokawa J-I. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules 2009; 10:2074-2085.
51. Friedman AJ, Han G, Navati M.S., Chacko M., Gunther L, Alfieri A, Friedman JM. Sustained release nitric oxide releasing nanopar-ticles: Characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008; 19:12-20.
52. Seabra AB, da Silva R, de Souza GFP, de Oliveira MG. Antithrom-bogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces. Artif Organs 2008; 32: 262-267.